Onkure Therapeutics, Inc. · NASDAQ:OKUR

BVF PARTNERS L P/IL reported a 5.30% stake in Onkure Therapeutics, Inc. (Schedule 13G)

Event May 19, 2026 · Filed May 27, 2026

BVF PARTNERS L P/IL reported a 5.30% stake in Onkure Therapeutics, Inc., 2,134,908 shares, as a passive investor on May 19, 2026. Filed May 27, 2026 (Schedule 13G).

Stake
5.30%
Shares
2,134,908
Intent
Passive
What changed
Crossed above 5%
Filed together
10 holders

The filing in full

HolderStakeShares
BIOTECHNOLOGY VALUE FUND L P2.70%1,095,373
BVF I GP LLC2.70%1,095,373
BIOTECHNOLOGY VALUE FUND II LP2.10%854,705
BVF II GP LLC2.10%854,705
Biotechnology Value Trading Fund OS LP0.40%153,595
BVF Partners OS Ltd.0.40%153,595
BVF GP HOLDINGS LLC4.80%1,950,078
BVF PARTNERS L P/IL5.30%2,134,908
BVF INC/IL5.30%2,134,908
LAMPERT MARK N5.30%2,134,908

Source

View original at SEC

Related